
Welcome to Spherium Biomed
Spherium is a company that develops biomedical innovations from academic sources to accelerate their transition to the value chain and to the market.

Our key factors

ENTREPRENEURIAL
MINDSET
Hands-on approach to manage projects with proactivity and flexibility, willing to accept risk and to share success with our partners

KNOWLEDGE OF RESEARCH ENVIROMENT
Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator

UNDERSTANDING INDUSTRIAL NEEDS
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry

FOCUS ON PROJECT MANAGEMENT
Smart approach to project management that helps speed up development stages and decision making

INVESTMENT
CAPABILITY
Availability of own investment up to 500k€ per project allows us to reach the next value milestone
Our proposal in 3 steps

Licensing-in biomedical technology
We look for innovation opportunities both in universities &research institutions, and biotech & Pharmaceutical companies

Transforming knowledge into products
After thorough analysis and planning, we conduct the key activities and experiments to achieve the next value milestone

Finding the best way to market
We look for the optimal partner (VC, Pharma…) to keep the project in track towards its next milestone
Highlight projects
-
- Preclinical POC
- Clinical POC
- Partnered
-
-
SP11057
Aptamers anti-lipoprotein A IV (Apo A IV) - Cancelled
-
-
SP11057
-
-
SP13004
Prevention and treatment of mucositis induced by cancer chemoradiotherapy
-
-
SP13004
-
-
SP14019
Topical treatment for psoriasis and atopic dermatitis
-
-
SP14019
-
-
SP12008
Immunomodulatory biological for the treatment of auto-immune diseases
-
-
SP12008
-
-
SP14037
Biological for the treatment of Amyotrophic Lateral Sclerosis (ALS). Project canceled
-
-
SP14037